TITLE

Controlling Spending for Prescription Drugs

AUTHOR(S)
Altman, Stuart H.; Parks-Thomas, Cindy
PUB. DATE
March 2002
SOURCE
New England Journal of Medicine;3/14/2002, Vol. 346 Issue 11, p855
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
Editorial. Focuses on the cost of prescription drugs in the United States. Problems with the cost of drugs for those who do not have health insurance; Cost of drugs for the elderly; Study in this issue by Lewis et al on discount drug programs for the elderly; How improving the affordability of prescription drugs must be a top priority; Need for physicians to become involved.
ACCESSION #
24921548

 

Related Articles

  • The high cost of medicines in Ireland. Tilson, Lesley; McGowan, Bernadette; Bennett, Kathleen; Barry, Michael // European Journal of Health Economics;Dec2004, Vol. 5 Issue 4, p341 

    This study compared the prices of prescription medicines in Ireland to those in other countries to determine potential cost savings on the largest community drug scheme if an alternative pricing mechanism were adopted. The analysis covered a sample of 39 drugs (44.8% of the total ingredient...

  • Prescribing data shows slowdown in drug spending. Polak, Monika // GP: General Practitioner;5/3/2004, p5 

    The increase in prescribing costs has slowed down, according to data from the Prescription Pricing Authority (PPA) published last week. The PPA prescribing cost analysis for 2003 showed that almost 650 million prescription items were dispensed in 2003, costing just over pounds 7.51 billion....

  • Short-term Rx cuts could lead to long-term cost increases.  // Westchester County Business Journal;6/10/2002, Vol. 41 Issue 23, p20 

    Talks about the impact of prescription drug on health care cost increases. Factors that contributed to rising prescription drug costs; Steps that employers should consider to mitigate rising health care costs.

  • Free drug samples lead to greater out-of-pocket spending.  // PharmacoEconomics & Outcomes News;4/5/2008, Issue 550, p6 

    The article discusses research on the higher prescription costs by patients who receive free drug samples than those who do not. It references a study by the University of Chicago Medical Center released to the media on March 24, 2008. According to the study, medicines given as free samples are...

  • Copay assistance programs lead to higher healthcare costs.  // PharmacoEconomics & Outcomes News;10/22/2016, Vol. 764 Issue 1, p1 

    The article discusses findings of a study conducted by Peter Ubel of Duke University and Peter Bach of Memorial Sloan Kettering Cancer Center, on the impacts of copay assistance programs for expensive drugs in addressing the financial needs of patients and the risk of higher health care cost.

  • PPIs, TTOs, AND NICE GUIDELINES: DETERMINING HOW TO REDUCE PRESCRIBING COSTS. Nicholson, T.; Ingram, P.; Barman, P.; Murray, I. A. // Gut;Apr2004 Supplement 3, Vol. 53, pA22 

    This article presents information on PPIs, TTOs and NICE guidelines with the aim to reduce prescribing costs. Cornwall has the highest prescribing costs for PPIs in England and Wales. NICE has produced guidelines for cost effective PPI prescribing including treatment plans for dose and duration...

  • DRUG TRIPS. Gibbs, Lisa // Money;Sep2001, Vol. 30 Issue 9, p118 

    Details the trip of Americans who go to Canada to buy prescription drugs because of the high cost of drugs in the United States. How prescriptions can be filled for a three month supply and one refill; Issue of legality of the process, according to the U.S. Food and Drug Administration; Focus...

  • Drug Assistance from Drug Makers. Hanson, Karmen // State Legislatures;Jun2003, Vol. 29 Issue 6, p22 

    Reports on the effort of U.S. legislators to find ways to help low income and elderly people by leveraging free drugs from pharmaceutical manufactures as prescription drug costs increase as of June 2003. Requirement of free drug programs or patient assistance programs at drug companies for...

  • Healthcare spending still on the rise.  // Pharmaceutical Representative;Aug2005, Vol. 35 Issue 8, p14 

    Focuses on the decline in the rate of healthcare spending growth in the U.S. Impact of the health spending growth on the overall economic growth of the country; Increase in the prescription drug spending per privately insured person; Details on the spending for services provided in freestanding...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics